ArticleContemporary clinical trials2025

Assessing the role of correlation between efficacy and toxicity endpoints in the performance of Bayesian optimal phase II design.

Xun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.